To further examine the timing and location of NRP1 in PCa, we relied upon a publicly available single-cell RNAseq (scRNAseq) analysis of 13 tumour biopsies from 12 PCa patients, including those with luminal, basal, or proliferative phenotypes [25] for details). This evidence concerns the gene NRP1 and neoplasm.